The use of diabetes technology such as continuous subcutaneous insulin infusion, also known as the insulin pump, continuous glucose monitors, and their integration into automated insulin delivery (AID) systems are associated with improved glycemic management in children and adolescents with type 1 diabetes (2). The gene discussed is INS; the disease is type 1 diabetes mellitus.